中文 | English

New innovation in the field of diabetes and it's complications – new targets and findings in China and global.
Are you ready?

Event details

DATE
Thursday,May 14, 2020

VENUE
Online Webex / Gotomeeting

TIME
9am -10am (Berlin time) | 3:00 PM - 4:00 PM (Beijing time)

RSVP
This is a complimentary event
VIP tckets priority for Lingmed current clients
Please RSVP by May 10, 2020
PRESENTERS
Lingling Cao, CEO & Founder
Dr Hank Wang, Medical advisor

REGISTER
+86 21 5386 3003
info@lingmed.net

Agenda

CET 9am - 9:10amLinkedbio services & projects introductions    by LingLing Cao
CET 9:10 - 9:55New innovation in the field of diabetes and it's complications – new targets and findings in China and global.   by Dr Hank Wang
CET 9:55 - 10:00Q&A  

Presenters

Lingling Cao
CEO & Founder
Lingling has more than a decade of experience in the healthcare industry, especially in deal-making. She founded Lingmed, which aims to support BD professionals to make better decisions with intelligence databases and EU-China cross-border deals. Prior to her venture at Lingmed, she was a senior BD manager for Eli Lilly in Shanghai and a consultant for McKinsey in Germany

Hank Wang
Medical advisor
Dr Wang holds a PhD degree on Medicinal Chemistry from Peking University, has a Postdoc experience in University of Missouri-Saint Louis, and worked as a Postdoc Fellow in Auburn University. Hank Wang has more than 10 years’ experience in pharmaceuticals industry. Hank has worked as Vice President and President of R&D at Beijing Haiyan Pharmaceutical Co., Ltd. - Yangtze River Pharmaceutical Group. Dr Wang advises Lingmed on innovative assets evaluation for China market
Download meeting reports
©Copyright 2013 - 2020 Lingmed Limited